Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate

C. Arnold Spek, JanWillem Duitman

Source: ERJ Open Res, 5 (1) 00157-2018; 10.1183/23120541.00157-2018
Journal Issue: February
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Arnold Spek, JanWillem Duitman. Is idiopathic pulmonary fibrosis a cancer-like disease? Transcriptome analysis to fuel the debate. ERJ Open Res, 5 (1) 00157-2018; 10.1183/23120541.00157-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does emphysema coexistence with IPF change prognosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis?
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013

Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014


The ratio AGE/RAGE is increased in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015


MiR-214-3p, a new fibromiR involved in the pathogenesis of idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014

Prognostic impact of typical and probable usual interstitial pneumonia pattern in idiopathic pulmonary fibrosis: is the debate about biopsy a Star Wars saga?
Source: Eur Respir J, 55 (4) 2000590; 10.1183/13993003.00590-2020
Year: 2020



Distinct clinical and pathological phenotypes in IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease
Source: Eur Respir J 2016; 48: 26-28
Year: 2016


Idiopathic pulmonary fibrosis: recent milestones in disease management
Source: Eur Respir Rev 2012; 21: 140
Year: 2012


Analysis of candidate genes of phenotypic expression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014


Idiopathic pulmonary fibrosis: a treatable disease?
Source: Eur Respir J 2003 Dec 01;22(6):872-873
Year: 2003


Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013

Combined emphysema & interstitial pulmonary disease. A new disease entity?
Source: Eur Respir J 2002; 20: Suppl. 38, 587s
Year: 2002

Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment
Source: Virtual Congress 2020 – When the lung gets stiff
Year: 2020


Club cell secretory protein-CC16 is increased in idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016


Insights into idiopathic pulmonary fibrosis in the real world
Source: Eur Respir J 2015; 46: 16-18
Year: 2015


A recurring theme in pulmonary fibrosis genetics
Source: Eur Respir J, 49 (5) 1700545; 10.1183/13993003.00545-2017
Year: 2017



Severe lung inflammation is a feature of IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020